S

Shenzhen Salubris Pharmaceuticals Co Ltd
SZSE:002294

Watchlist Manager
Shenzhen Salubris Pharmaceuticals Co Ltd
SZSE:002294
Watchlist
Price: 58.7 CNY -0.83% Market Closed
Market Cap: 65.4B CNY

Intrinsic Value

The intrinsic value of one Shenzhen Salubris Pharmaceuticals Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 58.7 CNY, Shenzhen Salubris Pharmaceuticals Co Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

Shenzhen Salubris Pharmaceuticals Co Ltd Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Shenzhen Salubris Pharmaceuticals Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Shenzhen Salubris Pharmaceuticals Co Ltd looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether Shenzhen Salubris Pharmaceuticals Co Ltd usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about Shenzhen Salubris Pharmaceuticals Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Shenzhen Salubris Pharmaceuticals Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Shenzhen Salubris Pharmaceuticals Co Ltd.

Explain Valuation
Compare Shenzhen Salubris Pharmaceuticals Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Shenzhen Salubris Pharmaceuticals Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Shenzhen Salubris Pharmaceuticals Co Ltd

Current Assets 4.3B
Cash & Short-Term Investments 2.9B
Receivables 795.3m
Other Current Assets 581.6m
Non-Current Assets 6.4B
Long-Term Investments 1.2B
PP&E 1.4B
Intangibles 3.4B
Other Non-Current Assets 328.1m
Current Liabilities 1.3B
Accounts Payable 148m
Accrued Liabilities 765.8m
Short-Term Debt 193.5m
Other Current Liabilities 164.4m
Non-Current Liabilities 816.9m
Long-Term Debt 3.7m
Other Non-Current Liabilities 813.2m
Efficiency

Free Cash Flow Analysis
Shenzhen Salubris Pharmaceuticals Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Shenzhen Salubris Pharmaceuticals Co Ltd

Revenue
4.3B CNY
Cost of Revenue
-1.1B CNY
Gross Profit
3.1B CNY
Operating Expenses
-2.5B CNY
Operating Income
632.7m CNY
Other Expenses
39.8m CNY
Net Income
672.6m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Shenzhen Salubris Pharmaceuticals Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Healthy Operating Margin
Sustainable 3Y Average Operating Margin
hidden
Profitability
Score

Shenzhen Salubris Pharmaceuticals Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Shenzhen Salubris Pharmaceuticals Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Negative Net Debt
Low D/E
hidden
Solvency
Score

Shenzhen Salubris Pharmaceuticals Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Shenzhen Salubris Pharmaceuticals Co Ltd

Wall Street analysts forecast Shenzhen Salubris Pharmaceuticals Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shenzhen Salubris Pharmaceuticals Co Ltd is 47.2 CNY with a low forecast of 46.73 CNY and a high forecast of 48.58 CNY.

Lowest
Price Target
46.73 CNY
20% Downside
Average
Price Target
47.2 CNY
20% Downside
Highest
Price Target
48.58 CNY
17% Downside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Shenzhen Salubris Pharmaceuticals Co Ltd is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Shenzhen Salubris Pharmaceuticals Co Ltd stock?

The intrinsic value of one Shenzhen Salubris Pharmaceuticals Co Ltd stock under the Base Case scenario is hidden CNY.

Is Shenzhen Salubris Pharmaceuticals Co Ltd stock undervalued or overvalued?

Compared to the current market price of 58.7 CNY, Shenzhen Salubris Pharmaceuticals Co Ltd is hidden .

Back to Top